cui A, Braunwald O, Kasper D, Hauser S, Longo D, Jameson J, et al, eds. Principles of internal medicine. 17th ed. New York: McGraw-Hill; 2008. P. 2274.
2-Larijani BZ, Zahedi F. [Epidemiology of diabetes mellitus in Iran]. Iraninan Journal of diabetes and lipid disorders 2002;1:1-8. [In Persian]
3-Tesfaye s, Stevens LK, Stephenson JM,
Fuller JH,
Plater M,
Ionescu-Tirgoviste C, et al. Prevalence of diabetic peripheral neuropathy and its reation to glycaemic control and potential risk factors: the EURODIAB IDDN Complications Study. Diabetologia 1996;39(11):1377-84.
4-Knuiman MW, Welborn TA, McCann VJ, Stanton KG, Constable IJ. Prevalence of diabetic complications in relation to risk factors. Diabetes 1986;35(12):1332-9.
5-Tesfaye S, Chaturvedi N, Eaton SEM, Ward JD, Manes C, Ionescu-Tirgoviste C, et al. Vascul risk factors and diabetic neuropathy. New Engl J Med 2005;352:341-50.
6-Booya F, Bandarian F, Larijani B,
Pajouhi M,
Nooraei M,
Lotfi J. Potential rik factors for diabetic neuropathy: a case control study. BMC Neurol 2005;5:24.
7-Janghorbani M,Rezvanian H,Kachooei A,Ghorbani A,Chitsaz A,Isadi F,Amin M.peripheral neuropathy in type 2 diabetes mellitus in Isfahan,Iran:prevalence and risk factors.Acta Neurol scand 2006 Dec,114(6):384-91.
8-Valensi P, Giroux C,
Seeboth-Ghalayini B, Attali JR. Diabetic peripheral neuropathy: effects of age, duration of diabetes, glycemic control, and Vascular factors. J Diabetes Complications 1997;11(1):27-34.
9-Akbar DH, Mira SA, Zawawi TH, Malibary HM. Subclinical diabetic neuropathy: a common complication in Saudi diabetics. Saudi Med J 2000;21(5):433-7.
10-Yadollah Harati and E. Peter Bosch in chapter 80 ; Walter G. Bradley in neurology in clinical practice; 2008, fifth edition.